Abstract
Sickle cell disease (SCD) is a hereditary disorder that is so named for the presence of characteristic malformed sickle-shaped red blood cells (RBCs). These abnormal RBCs are short-lived and can also cause vaso-occlusion throughout the body, which may lead to ischemia and infarcts in multiple organ systems. Neurovascular complications of SCD include cerebral vasculopathy, such as stroke and neurocognitive deficits, which are significant causes of morbidity and mortality in both children and adults. In current clinical practice, various conventional imaging tools, such as computed tomography (CT), magnetic resonance imaging (MRI), and catheter angiogram, still play an important role in diagnosis and follow-up of neurovascular complications of SCD. Ultrasounds, including transcranial Doppler (TCD) ultrasound, are useful in screening for intra- and extracranial vasculopathy. Advanced imaging techniques, such as diffusion tensor imaging (DTI), perfusion imaging, MR spectroscopy, quantitative MRI (qMRI), and nuclear medicine such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET), are emerging as diagnostic tools in the evaluation of SCD.
In this chapter, a brief overview of the etiology, classification, pathophysiology, epidemiology, clinical manifestation, and treatment of SCD is provided. The complications of SCD seen across the spectrum of conventional to advanced imaging modalities are also illustrated and discussed. The focus is on neurovascular complications and its management, but there will also be a discussion of posterior reversible encephalopathy syndrome, craniofacial osseous complications, and inner ear complications, which may be encountered in the daily neuroradiology practice.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet 376:2018–2031
Steinberg MH (2008) Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. Sci World J 8:1295–1324
Steen RG, Hankins GM, Xiong X, Wang WC, Beil K, Langston JW, Helton KJ (2003) Prospective brain imaging evaluation of children with sickle cell trait: initial observations. Radiology 228:208–215
Kanter J, Kruse-Jarres R (2013) Management of sickle cell disease from childhood through adulthood. Blood Rev 27:279–287
Connes P, Verlhac S, Bernaudin F (2013) Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. Br J Haematol 161:484–498
Lonergan GJ, Cline DB, Abbondanzo SL (2001) Sickle cell anemia. Radiographics 21:971–994
Moran CJ, Siegel MJ, DeBaun MR (1998) Sickle cell disease: imaging of cerebrovascular complications. Radiology 206:311–321
Moritani T, Numaguchi Y, Lemer NB, Rozans MK, Robinson AE, Hiwatashi A, Westesson PL (2004) Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography. Clin Imaging 28:173–186
Glushakova S, Balaban A, McQueen PG, Coutinho R, Miller JL, Nossal R, Fairhurst RM, Zimmerberg J (2014) Hemoglobinopathic erythrocytes affect the intraerythrocytic multiplication of Plasmodium falciparum in vitro. J Infect Dis 210:1100–1109
Halasa NB, Shankar SM, Talbot TR, Arbogast PG, Mitchel EF, Wang WC, Schaffner W, Craig AS, Griffin MR (2007) Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 44:1428–1433
Quinn CT, Rogers ZR, McCavit TL, Buchanan GR (2010) Improved survival of children and adolescents with sickle cell disease. Blood 115:3447–3452
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639–1644
Watanabe M, Saito N, Nadgir RN, Liao JH, Flower EN, Steinberg MH, Sakai O (2013) Craniofacial bone infarcts in sickle cell disease: clinical and radiological manifestations. J Comput Assist Tomogr 37:91–97
Gladwin MT, Vichinsky E (2008) Pulmonary complications of sickle cell disease. N Engl J Med 359:2254–2265
Ejindu VC, Hine AL, Mashayekhi M, Shorvon PJ, Misra RR (2007) Musculoskeletal manifestations of sickle cell disease. Radiographics 27:1005–1021
Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91:288–294
Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, Vichinsky EP, DeBaun MR, Guarini L, Zimmerman RA, Younkin DP, Gallagher DM, Kinney TR (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 99:3014–3018
Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA, DeWitt LD, Gallagher DM, Guarini L, Moser FG, Ohene-Frempong K, Sanchez N, Vichinsky EP, Wang WC, Wethers DL, Younkin DP, Zimmerman RA, DeBaun MR, Cooperative Study of Sickle Cell D (2001) Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 139:385–390
Sidani CA, Ballourah W, El Dassouki M, Muwakkit S, Dabbous I, Dahoui H, Al-Kutoubi A, Abboud MR (2008) Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: treatment with thrombolysis. Am J Hematol 83:818–820
Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Jordan LB, Armstrong FD, Neuropsychological Dysfunction, Neuroimaging Adult Sickle Cell Anemia Study Group (2010) Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 303:1823–1831
Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, Gold JI, Kesler K, Brewer J, Weiner MW, Neuropsychological Dysfunction, Neuroimaging Adult Sickle Cell Anemia Study Group (2014) Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology 82:835–841
Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332:1317–1322
DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF (2014) Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med 371:699–710
Hulbert ML, Scothorn DJ, Panepinto JA, Scott JP, Buchanan GR, Sarnaik S, Fallon R, Chu JY, Wang W, Casella JF, Resar L, Berman B, Adamkiewicz T, Hsu LL, Smith-Whitley K, Mahoney D, Woods G, Watanabe M, DeBaun MR (2006) Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 149:710–712
Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339:5–11
Peinemann F, Bartel C, Grouven U (2013) First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. Cochrane Database Syst Rev 7, CD006407
Webb J, Kwiatkowski JL (2013) Stroke in patients with sickle cell disease. Expert Rev Hematol 6:301–316
Arkuszewski M, Melhem ER, Krejza J (2010) Neuroimaging in assessment of risk of stroke in children with sickle cell disease. Adv Med Sci 55:115–129
Smajlovic D, Sinanovic O (2004) Sensitivity of the neuroimaging techniques in ischemic stroke. Med Arh 58:282–284
Paonessa A, Limbucci N, Tozzi E, Splendiani A, Gallucci M (2010) Radiological strategy in acute stroke in children. Eur J Radiol 74:77–85
Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, Ferriero D, Jones BV, Kirkham FJ, Scott RM, Smith ER, American Heart Association Stroke Council, Council on Cardiovascular Disease in the Young (2008) Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 39:2644–2691
Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF, Rordorf G, Wang B, Sorensen AG, Koroshetz WJ (1999) Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 210:155–162
Rydberg JN, Hammond CA, Grimm RC, Erickson BJ, Jack CR Jr, Huston J 3rd, Riederer SJ (1994) Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 193:173–180
Cheng AL, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M, Smith EE (2013) Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke 44:2782–2786
Strouse JJ, Lanzkron S, Urrutia V (2011) The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease. Expert Rev Hematol 4:597–606
Frietsch T, Ewen I, Waschke KF (2001) Anaesthetic care for sickle cell disease. Eur J Anaesthesiol 18:137–150
Maeda M, Tsuchida C (1999) “Ivy sign” on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR Am J Neuroradiol 20:1836–1838
Brandao RA, de Carvalho GT, Reis BL, Bahia E, de Souza AA (2009) Intracranial aneurysms in sickle cell patients: report of 2 cases and review of the literature. Surg Neurol 72:296–299 (discussion 299)
Santhosh K, Kesavadas C, Thomas B, Gupta AK, Thamburaj K, Kapilamoorthy TR (2009) Susceptibility weighted imaging: a new tool in magnetic resonance imaging of stroke. Clin Radiol 64:74–83
Lu L, Zhang LJ, Poon CS, Wu SY, Zhou CS, Luo S, Wang M, Lu GM (2012) Digital subtraction CT angiography for detection of intracranial aneurysms: comparison with three-dimensional digital subtraction angiography. Radiology 262:605–612
Sailer AM, Wagemans BA, Nelemans PJ, de Graaf R, van Zwam WH (2014) Diagnosing intracranial aneurysms with MR angiography. systematic review and meta-analysis. Stroke 45:119–126
Kwiatkowski JL, Zimmerman RA, Pollock AN, Seto W, Smith-Whitley K, Shults J, Blackwood-Chirchir A, Ohene-Frempong K (2009) Silent infarcts in young children with sickle cell disease. Br J Haematol 146:300–305
Pegelow CH, Wang W, Granger S, Hsu LL, Vichinsky E, Moser FG, Bello J, Zimmerman RA, Adams RJ, Brambilla D, Trial S (2001) Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol 58:2017–2021
Dowling MM, Quinn CT, Rogers ZR, Buchanan GR (2010) Acute silent cerebral infarction in children with sickle cell anemia. Pediatr Blood Cancer 54:461–464
Kinney TR, Sleeper LA, Wang WC, Zimmerman RA, Pegelow CH, Ohene-Frempong K, Wethers DL, Bello JA, Vichinsky EP, Moser FG, Gallagher DM, DeBaun MR, Platt OS, Miller ST (1999) Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 103:640–645
Wang WC, Gallagher DM, Pegelow CH, Wright EC, Vichinsky EP, Abboud MR, Moser FG, Adams RJ (2000) Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol 22:335–339
Arkuszewski M, Krejza J, Chen R, Ichord R, Kwiatkowski JL, Bilello M, Zimmerman R, Ohene-Frempong K, Melhem ER (2014) Sickle cell anemia: Intracranial stenosis and silent cerebral infarcts in children with low risk of stroke. Adv Med Sci 59:108–113
Schatz J, White DA, Moinuddin A, Armstrong M, DeBaun MR (2002) Lesion burden and cognitive morbidity in children with sickle cell disease. J Child Neurol 17:891–895
DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ (2012) Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 119:4587–4596
Steen RG, Miles MA, Helton KJ, Strawn S, Wang W, Xiong X, Mulhern RK (2003) Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit. AJNR Am J Neuroradiol 24:382–389
Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR (2011) Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood 117:772–779
Casella JF, King AA, Barton B, White DA, Noetzel MJ, Ichord RN, Terrill C, Hirtz D, McKinstry RC, Strouse JJ, Howard TH, Coates TD, Minniti CP, Campbell AD, Vendt BA, Lehmann H, Debaun MR (2010) Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol 27:69–89
Steen RG, Emudianughe T, Hankins GM, Wynn LW, Wang WC, Xiong X, Helton KJ (2003) Brain imaging findings in pediatric patients with sickle cell disease. Radiology 228:216–225
Gibbs WN, Opatowsky MJ, Burton EC (2012) AIRP best cases in radiologic-pathologic correlation: cerebral fat embolism syndrome in sickle cell beta-thalassemia. Radiographics 32:1301–1306
Mossa-Basha M, Izbudak I, Gurda GT, Aygun N (2012) Cerebral fat embolism syndrome in sickle cell anaemia/beta-thalassemia: importance of susceptibility-weighted MRI. Clin Radiol 67:1023–1026
Currie S, Raghavan A, Batty R, Connolly DJ, Griffiths PD (2011) Childhood moyamoya disease and moyamoya syndrome: a pictorial review. Pediatr Neurol 44:401–413
Amlie-Lefond C, Bernard TJ, Sebire G, Friedman NR, Heyer GL, Lerner NB, DeVeber G, Fullerton HJ, International Pediatric Stroke Study Group (2009) Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation 119:1417–1423
Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, Abboud MR (2002) Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 99:3144–3150
Lin N, Baird L, Koss M, Kopecky KE, Gone E, Ullrich NJ, Scott RM, Smith ER (2011) Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression. Neurosurg Focus 31:E6
Arias EJ, Derdeyn CP, Dacey RG Jr, Zipfel GJ (2014) Advances and surgical considerations in the treatment of moyamoya disease. Neurosurgery 74:S116–S125
Adelson PD, Scott RM (1995) Pial synangiosis for moyamoya syndrome in children. Pediatr Neurosurg 23:26–33
Robertson RL, Burrows PE, Barnes PD, Robson CD, Poussaint TY, Scott RM (1997) Angiographic changes after pial synangiosis in childhood moyamoya disease. AJNR Am J Neuroradiol 18:837–845
Kennedy BC, McDowell MM, Yang PH, Wilson CM, Li S, Hankinson TC, Feldstein NA, Anderson RC (2014) Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases. Neurosurg Focus 36:E12
Calviere L, Viguier A, Guidolin B, Tall P, Larrue V (2007) Cervical artery stenoses in sickle cell disease. Eur Neurol 58:120–121
Deane CR, Goss D, Bartram J, Pohl KR, Height SE, Sibtain N, Jarosz J, Thein SL, Rees DC (2010) Extracranial internal carotid arterial disease in children with sickle cell anemia. Haematologica 95:1287–1292
Telfer PT, Evanson J, Butler P, Hemmaway C, Abdulla C, Gadong N, Whitmarsh S, Kaya B, Kirkham FJ (2011) Cervical carotid artery disease in sickle cell anemia: clinical and radiological features. Blood 118:6192–6199
Verlhac S, Balandra S, Cussenot I, Kasbi F, Vasile M, Kheniche A, Elmaleh-Berges M, Ithier G, Benkerrou M, Bernaudin F, Sebag G (2014) Extracranial carotid arteriopathy in stroke-free children with sickle cell anemia: detection by submandibular Doppler sonography. Pediatr Radiol 44:587–596
Saito N, Nadgir RN, Flower EN, Sakai O (2010) Clinical and radiologic manifestations of sickle cell disease in the head and neck. Radiographics 30:1021–1034
Steen RG, Reddick WE, Glass JO, Wang WC (1998) Evidence of cranial artery ectasia in sickle cell disease patients with ectasia of the basilar artery. J Stroke Cerebrovasc Dis 7:330–338
Frye RE (2009) Reversible posterior leukoencephalopathy syndrome in sickle-cell anemia. Pediatr Neurol 40:298–301
Geevasinga N, Cole C, Herkes GK, Barnett Y, Lin J, Needham M (2014) Sickle cell disease and posterior reversible leukoencephalopathy. J Clin Neurosci 21:1329–1332
Henderson JN, Noetzel MJ, McKinstry RC, White DA, Armstrong M, DeBaun MR (2003) Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood 101:415–419
Khademian Z, Speller-Brown B, Nouraie SM, Minniti CP (2009) Reversible posterior leuko-encephalopathy in children with sickle cell disease. Pediatr Blood Cancer 52:373–375
Kolovou V, Zampakis P, Ginopoulou A, Varvarigou A, Kaleyias J (2013) Reversible posterior leukoencephalopathy syndrome after blood transfusion in a pediatric patient with sickle cell disease. Pediatr Neurol 49:213–217
Elias EJ, Liao JH, Jara H, Watanabe M, Nadgir RN, Sakai Y, Erbay K, Saito N, Ozonoff A, Steinberg MH, Sakai O (2013) Quantitative MRI analysis of craniofacial bone marrow in patients with sickle cell disease. AJNR Am J Neuroradiol 34:622–627
Liao JH, Jara H, Nadgir R, Elias E, Nowrouzi N, Saito N, Steinberg MH, Sakai O (2013) qMRI relaxometry of mandibular bone marrow: a monomodal distribution in sickle cell disease. J Magn Reson Imaging 37:1182–1188
Marlow TJ, Brunson CY, Jackson S, Schabel SI (1998) “Tower vertebra”: a new observation in sickle cell disease. Skeletal Radiol 27:195–198
Jain R, Sawhney S, Rizvi SG (2008) Acute bone crises in sickle cell disease: the T1 fat-saturated sequence in differentiation of acute bone infarcts from acute osteomyelitis. Clin Radiol 63:59–70
Saito N, Watanabe M, Liao J, Flower EN, Nadgir RN, Steinberg MH, Sakai O (2011) Clinical and radiologic findings of inner ear involvement in sickle cell disease. AJNR AmJ Neuroradiol 32:2160–2164
Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H (2001) Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 13:534–546
Balci A, Karazincir S, Beyoglu Y, Cingiz C, Davran R, Gali E, Okuyucu E, Egilmez E (2012) Quantitative brain diffusion-tensor MRI findings in patients with sickle cell disease. AJR Am J Roentgenol 198:1167–1174
Behpour AM, Shah PS, Mikulis DJ, Kassner A (2013) Cerebral blood flow abnormalities in children with sickle cell disease: a systematic review. Pediatr Neurol 48:188–199
Kirkham FJ, Calamante F, Bynevelt M, Gadian DG, Evans JP, Cox TC, Connelly A (2001) Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol 49:477–485
Oguz KK, Golay X, Pizzini FB, Freer CA, Winrow N, Ichord R, Casella JF, van Zijl PC, Melhem ER (2003) Sickle cell disease: continuous arterial spin-labeling perfusion MR imaging in children. Radiology 227:567–574
Strouse JJ, Cox CS, Melhem ER, Lu H, Kraut MA, Razumovsky A, Yohay K, van Zijl PC, Casella JF (2006) Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA). Blood 108:379–381
van den Tweel XW, Nederveen AJ, Majoie CB, van der Lee JH, Wagener-Schimmel L, van Walderveen MA, Poll The BT, Nederkoorn PJ, Heijboer H, Fijnvandraat K (2009) Cerebral blood flow measurement in children with sickle cell disease using continuous arterial spin labeling at 3.0-Tesla MRI. Stroke 40:795–800
Sanelli PC, Sykes JB, Ford AL, Lee JM, Vo KD, Hallam DK (2013) Imaging and treatment of patients with acute stroke: an evidence-based review. AJNR Am J Neuroradiol 35:1045–1051
Wang Z, Bogdan AR, Zimmerman RA, Gusnard DA, Leigh JS, Ohene-Frempong K (1992) Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy. Neuroradiology 35:57–65
Wang Z, Zimmerman RA, Sauter R (1996) Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR Am J Roentgenol 167:191–199
Steen RG, Ogg RJ (2005) Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease. AJNR Am J Neuroradiol 26:463–468
Watanabe M, Liao JH, Jara H, Sakai O (2013) Multispectral quantitative MR imaging of the human brain: lifetime age-related effects. Radiographics 33:1305–1319
Steen RG, Langston JW, Ogg RJ, Xiong X, Ye Z, Wang WC (1999) Diffuse T1 reduction in gray matter of sickle cell disease patients: evidence of selective vulnerability to damage? Magn Reson Imaging 17:503–515
Steen RG, Schroeder J (2003) Age-related changes in the pediatric brain: proton T1 in healthy children and in children with sickle cell disease. Magn Reson Imaging 21:9–15
Steen RG, Emudianughe T, Hunte M, Glass J, Wu S, Xiong X, Reddick WE (2005) Brain volume in pediatric patients with sickle cell disease: evidence of volumetric growth delay? AJNR Am J Neuroradiol 26:455–462
Liao J, Saito N, Ozonoff A, Jara H, Steinberg M, Sakai O (2012) Quantitative MRI analysis of salivary glands in sickle cell disease. Dentomaxillofac Radiol 41:630–636
Buch K, Watanabe M, Elias EJ, Liao JH, Jara H, Nadgir RN, Saito N, Steinberg MH, Sakai O (2014) Quantitative magnetic resonance imaging analysis of the Lacrimal gland in sickle cell disease. J Comput Assist Tomogr 38:674–680
Deus-Silva L, Bonilha L, Damasceno BP, Costa AL, Yasuda CL, Costa FF, Santos AO, Etchebehere EC, Oquendo-Nogueira R, Fockink R, de Freitas CF, Camargo EE, Li LM, Cendes F, Saad ST (2013) Brain perfusion impairment in neurologically asymptomatic adult patients with sickle-cell disease shown by Voxel-based analysis of SPECT images. Front Neurol 4:207
Kedar A, Drane WE, Shaeffer D, Nicole M, Adams C (2006) Measurement of cerebrovascular flow reserve in pediatric patients with sickle cell disease. Pediatr Blood Cancer 46:234–238
Powars DR, Conti PS, Wong WY, Groncy P, Hyman C, Smith E, Ewing N, Keenan RN, Zee CS, Harold Y, Hiti AL, Teng EL, Chan LS (1999) Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood 93:71–79
Reed W, Jagust W, Al-Mateen M, Vichinsky E (1999) Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol 60:268–272
Quinn CT, Rogers ZR, Buchanan GR (2004) Survival of children with sickle cell disease. Blood 103:4023–4027
Switzer JA, Hess DC, Nichols FT, Adams RJ (2006) Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 5:501–512
Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Chevret S, Hau I, Coic L, Leveille E, Lemarchand E, Lesprit E, Abadie I, Medejel N, Madhi F, Lemerle S, Biscardi S, Bardakdjian J, Galacteros F, Torres M, Kuentz M, Ferry C, Socie G, Reinert P, Delacourt C (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 117:1130–1140, quiz 436
Sheehan VA, Hansbury EN, Smeltzer MP, Fortner G, McCarville MB, Aygun B (2013) Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke. Pediatr Blood Cancer 60:1499–1502
Adams RJ, Nichols FT, Figueroa R, McKie V, Lott T (1992) Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 23:1073–1077
Jones A, Granger S, Brambilla D, Gallagher D, Vichinsky E, Woods G, Berman B, Roach S, Nichols F, Adams RJ (2005) Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol 35:66–72
Ishola T, Quinn CT (2013) Transcranial Doppler peak systolic velocities overestimate the risk of stroke in sickle cell anemia. Blood 122:2240
Scothorn DJ, Price C, Schwartz D, Terrill C, Buchanan GR, Shurney W, Sarniak I, Fallon R, Chu JY, Pegelow CH, Wang W, Casella JF, Resar LS, Berman B, Adamkiewicz T, Hsu LL, Ohene-Frempong K, Smith-Whitley K, Mahoney D, Scott JP, Woods GM, Watanabe M, Debaun MR (2002) Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 140:348–354
Madden NA, Jones GL, Kalpatthi R, Woods G (2014) Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: a survey of health care providers. J Pediatr Hematol Oncol 36:e382–e386
Ware RE, Helms RW, Investigators SW (2012) Stroke with transfusions changing to Hydroxyurea (SWiTCH). Blood 119:3925–3932
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this entry
Cite this entry
Fujita, A. et al. (2016). Sickle Cell Disease and Stroke. In: Saba, L., Raz, E. (eds) Neurovascular Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9029-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9029-6_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9028-9
Online ISBN: 978-1-4614-9029-6
eBook Packages: MedicineReference Module Medicine